{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:41:25Z","timestamp":1794850885765,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0531000"],"award-info":[{"award-number":["2024ZD0531000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171406\uff0c32201184"],"award-info":[{"award-number":["32171406\uff0c32201184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1104700, 2022YFA1205000, 2024YFA0919800"],"award-info":[{"award-number":["2022YFA1104700, 2022YFA1205000, 2024YFA0919800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dalian Science and technology Innovation Fund project","award":["2024JJ11PT006"],"award-info":[{"award-number":["2024JJ11PT006"]}]},{"name":"Innovation Program of Science and Research from the DICP, CAS","award":["DICPI202435"],"award-info":[{"award-number":["DICPI202435"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01074-z","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:24:22Z","timestamp":1768577062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A human liver organoids-on-chip for the assessment of drug-induced liver injury"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiyue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","volume":"4","author":"LY Rui","year":"2014","unstructured":"Rui LY. Energy metabolism in the liver. Compr Physiol. 2014;4:177\u201397.","journal-title":"Compr Physiol"},{"key":"1074_CR2","doi-asserted-by":"crossref","unstructured":"Andrade RJ, Chalasani N, Bj\u00f6rnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Reviews Disease Primers. 2019;5.","DOI":"10.1038\/s41572-019-0105-0"},{"key":"1074_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","volume":"66","author":"GA Kullak-Ublick","year":"2017","unstructured":"Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut. 2017;66:1154\u201364.","journal-title":"Gut"},{"key":"1074_CR4","doi-asserted-by":"crossref","unstructured":"Trammell SAJ, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li ZG, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 2016, 7.","DOI":"10.1038\/ncomms12948"},{"key":"1074_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.toxlet.2014.02.007","volume":"226","author":"BA Howell","year":"2014","unstructured":"Howell BA, Siler SQ, Watkins PB. Use of a systems model of drug-induced liver injury (DILIsym\u00ae) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice. Toxicol Lett. 2014;226:163\u201372.","journal-title":"Toxicol Lett"},{"key":"1074_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jat.3141","volume":"36","author":"S Takai","year":"2016","unstructured":"Takai S, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism. J Appl Toxicol. 2016;36:35\u201347.","journal-title":"J Appl Toxicol"},{"key":"1074_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","volume":"147","author":"F Shah","year":"2015","unstructured":"Shah F, Leung L, Barton HA, Will Y, Rodrigues AD, Greene N, Aleo MD. Setting clinical exposure levels of concern for Drug-Induced liver injury (DILI) using Mechanistic\u2009<\u2009i\u2009>\u2009in vitro\u2009Assays. Toxicol Sci. 2015;147:500\u201314.","journal-title":"Toxicol Sci"},{"key":"1074_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/toxres\/tfac083","volume":"12","author":"T Nukaga","year":"2023","unstructured":"Nukaga T, Takemura A, Endo Y, Uesawa Y, Ito K. Estimating drug-induced liver injury risk by in vitro molecular initiation response and Pharmacokinetic parameters for during early drug development. Toxicol Res. 2023;12:86\u201394.","journal-title":"Toxicol Res"},{"key":"1074_CR9","doi-asserted-by":"crossref","unstructured":"Ingber DE. Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies? Adv Sci 2020, 7.","DOI":"10.1002\/advs.202002030"},{"key":"1074_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760\u201372.","journal-title":"Nat Biotechnol"},{"key":"1074_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","volume":"16","author":"AMM Eggermont","year":"2015","unstructured":"Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015;16:522\u201330.","journal-title":"Lancet Oncol"},{"key":"1074_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","volume":"4","author":"GA Van Norman","year":"2019","unstructured":"Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials is it time to rethink our current approach? Jacc-Basic Translational Sci. 2019;4:845\u201354.","journal-title":"Jacc-Basic Translational Sci"},{"key":"1074_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/NDT.S50371","volume":"10","author":"L Kandratavicius","year":"2014","unstructured":"Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno LS, Leite JP. Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat. 2014;10:1693\u2013705.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1074_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa T, Kimura M, Cai Y, Saiki N, Yoneyama Y, Ouchi R, Koike H, Maezawa M, Zhang R-R, Dunn A, et al. High-Fidelity Drug-Induced liver injury screen using human pluripotent stem Cell-Derived organoids. Gastroenterology. 2021;160:831\u2013.","journal-title":"Gastroenterology"},{"key":"1074_CR15","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1039\/C5LC00611B","volume":"15","author":"DY No","year":"2015","unstructured":"No DY, Lee KH, Lee J, Lee SH. 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip. Lab Chip. 2015;15:3822\u201337.","journal-title":"Lab Chip"},{"key":"1074_CR16","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1039\/c3lc50240f","volume":"13","author":"EM Materne","year":"2013","unstructured":"Materne EM, Tonevitsky AG, Marx U. Chip-based liver equivalents for toxicity testing - organotypicalness\u2009<\u2009i\u2009>\u2009versus\u2009cost-efficient high throughput. Lab Chip. 2013;13:3481\u201395.","journal-title":"Lab Chip"},{"key":"1074_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","volume":"2","author":"L Ewart","year":"2022","unstructured":"Ewart L, Apostolou A, Briggs SA, Carman CV, Chaff JT, Heng AR, Jadalannagari S, Janardhanan J, Jang K-J, Joshipura SR, et al. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Commun Med. 2022;2:154.","journal-title":"Commun Med"},{"key":"1074_CR18","doi-asserted-by":"publisher","first-page":"eaax5516","DOI":"10.1126\/scitranslmed.aax5516","volume":"11","author":"K-J Jang","year":"2019","unstructured":"Jang K-J, Otieno MA, Ronxhi J, Lim H-K, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci Transl Med. 2019;11:eaax5516.","journal-title":"Sci Transl Med"},{"key":"1074_CR19","doi-asserted-by":"publisher","first-page":"lnad007","DOI":"10.1093\/lifemedi\/lnad007","volume":"2","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qin J. Advances in human organoids-on-chips in biomedical research. Life Med. 2023;2:lnad007.","journal-title":"Life Med"},{"key":"1074_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","volume":"78","author":"CJ Zhang","year":"2023","unstructured":"Zhang CJ, Meyer SR, O\u2019Meara MJ, Huang S, Capeling MM, Ferrer-Torres D, Childs CJ, Spence JR, Fontana RJ, Sexton JZ. A human liver organoid screening platform for DILI risk prediction. J Hepatol. 2023;78:998\u20131006.","journal-title":"J Hepatol"},{"key":"1074_CR21","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1039\/C8LC00869H","volume":"18","author":"YQ Wang","year":"2018","unstructured":"Wang YQ, Wang H, Deng PW, Chen WW, Guo YQ, Tao TT, Qin JH. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip. 2018;18:3606\u201316.","journal-title":"Lab Chip"},{"key":"1074_CR22","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1021\/acsbiomaterials.0c00682","volume":"6","author":"YQ Wang","year":"2020","unstructured":"Wang YQ, Wang H, Deng PW, Tao TT, Liu HT, Wu S, Chen WW, Qin JH. Modeling human nonalcoholic fatty liver disease (NAFLD) with an Organoids-on-a-Chip system. Acs Biomaterials Sci Eng. 2020;6:5734\u201343.","journal-title":"Acs Biomaterials Sci Eng"},{"key":"1074_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.actbio.2025.03.020","volume":"197","author":"R Panday","year":"2025","unstructured":"Panday R, Rogy KM, Han YD, Khetani SR. Engineered microtissues to model the effects of dynamic heterotypic cell signaling on iPSC-derived human hepatocyte maturation. Acta Biomater. 2025;197:135\u201351.","journal-title":"Acta Biomater"},{"key":"1074_CR24","doi-asserted-by":"publisher","first-page":"e2115867119","DOI":"10.1073\/pnas.2115867119","volume":"119","author":"A Chhabra","year":"2022","unstructured":"Chhabra A, Song HG, Grzelak KA, Polacheck WJ, Fleming HE, Chen CS, Bhatia SN. A vascularized model of the human liver mimics regenerative responses. Proc Natl Acad Sci U S A. 2022;119:e2115867119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1074_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MMA, Ellis E, van Wenum M, Fuchs SA, de Ligt J, et al. Long-Term culture of Genome-Stable bipotent stem cells from adult human liver. Cell. 2015;160:299\u2013312.","journal-title":"Cell"},{"key":"1074_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/hep.20081","volume":"39","author":"A Reuben","year":"2004","unstructured":"Reuben A. Hy\u2019s law. Hepatology. 2004;39:574\u20138.","journal-title":"Hepatology"},{"key":"1074_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586\u201397.","journal-title":"Cell"},{"key":"1074_CR28","doi-asserted-by":"publisher","first-page":"e2300390","DOI":"10.1002\/biot.202300390","volume":"19","author":"Y Guo","year":"2024","unstructured":"Guo Y, Xie Y, Qin J. A generic pump-free organ-on-a-chip platform for assessment of intestinal drug absorption. Biotechnol J. 2024;19:e2300390.","journal-title":"Biotechnol J"},{"key":"1074_CR29","doi-asserted-by":"crossref","unstructured":"Howell BA, Yang Y, Kumar R, Woodhead JL, Harrill AH, Clewell HJ 3rd, Andersen ME, Siler SQ, Watkins PB. In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym\u2122: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn. 2012;39:527\u201341.","DOI":"10.1007\/s10928-012-9266-0"},{"key":"1074_CR30","doi-asserted-by":"crossref","unstructured":"Howell BA, Yang Y, Kumar R, Woodhead JL, Harrill AH, Clewell HJ 3rd, Andersen ME, Siler SQ, Watkins PB. In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym\u2122: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn. 2012;39:527\u201341.","DOI":"10.1007\/s10928-012-9266-0"},{"key":"1074_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1124\/jpet.117.245712","volume":"365","author":"NA Kratochwil","year":"2018","unstructured":"Kratochwil NA, Triyatni M, Mueller MB, Klammers F, Leonard B, Turley D, Schmaler J, Ekiciler A, Molitor B, Walter I, et al. Simultaneous assessment of Clearance, Metabolism, induction, and Drug-Drug interaction potential using a Long-Term in vitro liver model for a novel hepatitis B virus inhibitor. J Pharmacol Exp Ther. 2018;365:237\u201348.","journal-title":"J Pharmacol Exp Ther"},{"key":"1074_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13578-024-01317-2","volume":"14","author":"K Guo","year":"2024","unstructured":"Guo K, van den Beucken T. Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques. Cell Biosci. 2024;14:134.","journal-title":"Cell Biosci"},{"key":"1074_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, Rautou PE. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol. 2017;66:212\u201327.","journal-title":"J Hepatol"},{"key":"1074_CR34","doi-asserted-by":"publisher","first-page":"1576739","DOI":"10.3389\/fimmu.2025.1576739","volume":"16","author":"T Yang","year":"2025","unstructured":"Yang T, Gu Z, Feng J, Shan J, Qian C, Zhuang N. Non-parenchymal cells: key targets for modulating chronic liver diseases. Front Immunol. 2025;16:1576739.","journal-title":"Front Immunol"},{"key":"1074_CR35","doi-asserted-by":"publisher","first-page":"101478","DOI":"10.1016\/j.dmpk.2025.101478","volume":"62","author":"I Fukunaga","year":"2025","unstructured":"Fukunaga I, Takebe T. In vitro liver models for toxicological research. Drug Metab Pharmacokinet. 2025;62:101478.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1074_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2018.08.001","volume":"85","author":"V Vilas-Boas","year":"2019","unstructured":"Vilas-Boas V, Cooreman A, Gijbels E, Van Campenhout R, Gustafson E, Ballet S, Annaert P, Cogliati B, Vinken M. Primary hepatocytes and their cultures for the testing of drug-induced liver injury. Adv Pharmacol. 2019;85:1\u201330.","journal-title":"Adv Pharmacol"},{"key":"1074_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.actbio.2020.08.041","volume":"116","author":"E Moradi","year":"2020","unstructured":"Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater. 2020;116:67\u201383.","journal-title":"Acta Biomater"},{"key":"1074_CR38","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1038\/s41467-021-23575-1","volume":"12","author":"N Tanimizu","year":"2021","unstructured":"Tanimizu N, Ichinohe N, Sasaki Y, Itoh T, Sudo R, Yamaguchi T, Katsuda T, Ninomiya T, Tokino T, Ochiya T, et al. Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo. Nat Commun. 2021;12:3390.","journal-title":"Nat Commun"},{"key":"1074_CR39","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/jat.4863","volume":"45","author":"X Liu","year":"2025","unstructured":"Liu X, Higuchi Y, Sakamoto Y, Yanagida S, Uehara S, Suemizu H, Kanda Y, Kawagishi H. In vitro assessment of Drug-Induced liver injury using Three-Dimensional cultured HepaSH cells derived from chimeric mouse model with humanized liver. J Appl Toxicol. 2025;45:2641\u201353.","journal-title":"J Appl Toxicol"},{"key":"1074_CR40","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, B\u00f6ttger J, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013;87:1315\u2013530.","journal-title":"Arch Toxicol"},{"key":"1074_CR41","doi-asserted-by":"publisher","first-page":"25329","DOI":"10.1038\/srep25329","volume":"6","author":"SS Bale","year":"2016","unstructured":"Bale SS, Geerts S, Jindal R, Yarmush ML. Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response. Sci Rep. 2016;6:25329.","journal-title":"Sci Rep"},{"key":"1074_CR42","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1038\/s41598-018-22749-0","volume":"8","author":"CD Edington","year":"2018","unstructured":"Edington CD, Chen WLK, Geishecker E, Kassis T, Soenksen LR, Bhushan BM, Freake D, Kirschner J, Maass C, Tsamandouras N, et al. Interconnected microphysiological systems for quantitative biology and Pharmacology studies. Sci Rep. 2018;8:4530.","journal-title":"Sci Rep"},{"key":"1074_CR43","first-page":"100054","volume":"7","author":"B Cox","year":"2022","unstructured":"Cox B, Barton P, Class R, Coxhead H, Delatour C, Gillent E, Henshall J, Isin EM, King L, Valentin JP. Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation. Biomater Biosyst. 2022;7:100054.","journal-title":"Biomater Biosyst"},{"key":"1074_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","volume":"32","author":"H Olson","year":"2000","unstructured":"Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000;32:56\u201367.","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01074-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01074-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:21:04Z","timestamp":1773674464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01074-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01074-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}